Molina Healthcare (MOH) Competitors

Molina Healthcare (NYSE:MOH) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations.

Does the media prefer MOH or HUM?

In the previous week, Humana had 13 more articles in the media than Molina Healthcare. MarketBeat recorded 35 mentions for Humana and 22 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.27 beat Humana's score of 0.52 indicating that Molina Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	14 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	19 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Is MOH or HUM more profitable?

Molina Healthcare has a net margin of 2.92% compared to Humana's net margin of 1.18%. Molina Healthcare's return on equity of 27.88% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	2.92%	27.88%	8.33%
Humana	1.18%	13.20%	4.47%

Which has stronger valuation and earnings, MOH or HUM?

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$34.07B	0.49	$1.09B	$19.69	14.95
Humana	$106.37B	0.31	$2.49B	$11.29	24.42

Do insiders & institutionals believe in MOH or HUM?

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 92.4% of Humana shares are held by institutional investors. 1.1% of Molina Healthcare shares are held by insiders. Comparatively, 0.3% of Humana shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in MOH or HUM?

Humana received 353 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 63.06% of users gave Humana an outperform vote while only 57.02% of users gave Molina Healthcare an outperform vote.

Company	Underperform	Outperform
Molina Healthcare	Outperform Votes 540 57.02%	Underperform Votes 407 42.98%
Humana	Outperform Votes 893 63.06%	Underperform Votes 523 36.94%

Do analysts prefer MOH or HUM?

Molina Healthcare currently has a consensus price target of $367.17, indicating a potential upside of 24.74%. Humana has a consensus price target of $315.86, indicating a potential upside of 14.58%. Given Molina Healthcare's stronger consensus rating and higher probable upside, research analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.46
Humana	0 Sell rating(s)	19 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.24

Which has more volatility and risk, MOH or HUM?

Molina Healthcare has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500.

Summary

Molina Healthcare beats Humana on 12 of the 19 factors compared between the two stocks.